Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | journal | 440573 | 5% | 26% | 1412 |
2 | HIV 1 | authKW | 399113 | 6% | 20% | 1692 |
3 | INFECTIOUS DISEASES | WoSSC | 348408 | 35% | 3% | 8989 |
4 | EFAVIRENZ | authKW | 335967 | 2% | 66% | 421 |
5 | ANTIRETROVIRAL THERAPY | authKW | 328869 | 4% | 23% | 1166 |
6 | HIV | authKW | 307894 | 12% | 9% | 3003 |
7 | VIROLOGY | WoSSC | 292131 | 26% | 4% | 6648 |
8 | NNRTIS | authKW | 283081 | 1% | 75% | 313 |
9 | AIDS | journal | 273020 | 5% | 16% | 1411 |
10 | INTEGRASE | authKW | 247852 | 1% | 59% | 351 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Infectious Diseases | 348408 | 35% | 3% | 8989 |
2 | Virology | 292131 | 26% | 4% | 6648 |
3 | Immunology | 69688 | 26% | 1% | 6665 |
4 | Pharmacology & Pharmacy | 25459 | 20% | 1% | 5227 |
5 | Microbiology | 19545 | 13% | 1% | 3286 |
6 | Chemistry, Medicinal | 11485 | 7% | 1% | 1800 |
7 | Biochemistry & Molecular Biology | 2363 | 13% | 0% | 3258 |
8 | Biochemical Research Methods | 2309 | 4% | 0% | 1066 |
9 | Medicine, General & Internal | 1332 | 5% | 0% | 1318 |
10 | Urology & Nephrology | 687 | 2% | 0% | 592 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AIDS | 164900 | 3% | 16% | 836 |
2 | INFECT DIS | 137928 | 12% | 4% | 3078 |
3 | HIV DRUG ISTANCE PROGRAM | 73135 | 1% | 32% | 188 |
4 | VIROL | 59808 | 5% | 4% | 1323 |
5 | REGA MED | 58007 | 2% | 12% | 392 |
6 | HIV UNIT | 54637 | 1% | 34% | 133 |
7 | RETROVIROL | 48927 | 1% | 22% | 189 |
8 | AIDS IMUNOL MOL | 48880 | 0% | 58% | 70 |
9 | ROYAL FREE HIV MED | 45054 | 0% | 46% | 82 |
10 | EXPT RETROVIROL SECT | 45001 | 0% | 52% | 72 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 440573 | 5% | 26% | 1412 |
2 | AIDS | 273020 | 5% | 16% | 1411 |
3 | ANTIVIRAL THERAPY | 202134 | 2% | 30% | 569 |
4 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 128903 | 3% | 16% | 693 |
5 | HIV MEDICINE | 80564 | 1% | 24% | 277 |
6 | HIV CLINICAL TRIALS | 70262 | 1% | 33% | 175 |
7 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 48494 | 1% | 15% | 271 |
8 | AIDS REVIEWS | 40194 | 0% | 34% | 97 |
9 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 34905 | 3% | 4% | 853 |
10 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 21465 | 2% | 4% | 486 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV 1 | 399113 | 6% | 20% | 1692 | Search HIV+1 | Search HIV+1 |
2 | EFAVIRENZ | 335967 | 2% | 66% | 421 | Search EFAVIRENZ | Search EFAVIRENZ |
3 | ANTIRETROVIRAL THERAPY | 328869 | 4% | 23% | 1166 | Search ANTIRETROVIRAL+THERAPY | Search ANTIRETROVIRAL+THERAPY |
4 | HIV | 307894 | 12% | 9% | 3003 | Search HIV | Search HIV |
5 | NNRTIS | 283081 | 1% | 75% | 313 | Search NNRTIS | Search NNRTIS |
6 | INTEGRASE | 247852 | 1% | 59% | 351 | Search INTEGRASE | Search INTEGRASE |
7 | NEVIRAPINE | 229099 | 1% | 55% | 345 | Search NEVIRAPINE | Search NEVIRAPINE |
8 | REVERSE TRANSCRIPTASE | 214015 | 2% | 35% | 504 | Search REVERSE+TRANSCRIPTASE | Search REVERSE+TRANSCRIPTASE |
9 | INTEGRASE INHIBITOR | 195314 | 1% | 78% | 207 | Search INTEGRASE+INHIBITOR | Search INTEGRASE+INHIBITOR |
10 | RALTEGRAVIR | 193667 | 1% | 70% | 229 | Search RALTEGRAVIR | Search RALTEGRAVIR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |